Suchergebnisse
Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- alnylam pharmaceuticals inc. 1 Treffer
- antineoplastics 1 Treffer
- antisense technology 1 Treffer
- bioengineering 1 Treffer
- biological factors 1 Treffer
-
36 weitere Werte:
- biomarkers 1 Treffer
- biopharmaceutical companies 1 Treffer
- biotechnology 1 Treffer
- blood protein disorders 1 Treffer
- bone marrow 1 Treffer
- bone research 1 Treffer
- cancer 1 Treffer
- cd antigens 1 Treffer
- diagnostics and screening 1 Treffer
- drugs and therapies 1 Treffer
- fc receptors 1 Treffer
- healthcare biotechnology companies 1 Treffer
- hematologic diseases and conditions 1 Treffer
- hematology 1 Treffer
- hemic and lymphatic diseases and conditions 1 Treffer
- hemorrhagic disorders 1 Treffer
- hemostatic disorders 1 Treffer
- immunoglobulins 1 Treffer
- immunoproliferative disorders 1 Treffer
- immunoproteins 1 Treffer
- lymphoproliferative disorders 1 Treffer
- membrane proteins 1 Treffer
- multiple myeloma 1 Treffer
- myeloma 1 Treffer
- nucleotide sequence 1 Treffer
- oncology 1 Treffer
- paraproteinemias 1 Treffer
- pharmaceutical companies 1 Treffer
- pharmaceuticals 1 Treffer
- proteasome inhibitors 1 Treffer
- proteins 1 Treffer
- rna 1 Treffer
- serum globulins 1 Treffer
- therapeutics 1 Treffer
- therapy 1 Treffer
- vascular diseases and conditions 1 Treffer
Publikation
Sprache
Inhaltsanbieter
2 Treffer
-
In: Pharma Business Week, 2023-05-15, S. 1660-1660serialPeriodicalZugriff:
-
In: Hematology Week, 2023-08-17, S. 1895-1895serialPeriodicalZugriff: